Profil
John Stubenrauch currently works at Nutcracker Therapeutics, Inc., as Chief Operating Officer from 2022 and Day One Biopharmaceuticals, Inc., as Chief Technology Officer from 2024.
Dr. Stubenrauch received his doctorate degree from the University of Pennsylvania and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Postes actifs de John Stubenrauch
| Sociétés | Poste | Début |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/07/2024 |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Directeur des opérations | 22/06/2022 |
Formation de John Stubenrauch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Offers technology solutions for biotechnology industry | Technology Services |
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
















